Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Clinical observation of the therapeutic effect of Ginkgo leaf concentrated oral liquor on bronchial asthma

  • 36 Accesses

Abstract

Objective: To determine the effects of Ginkgo leaf concentrated oral liquor (GLC) on airway inflammation.Methods: Airway hyperreactivity, clinical symptoms and pulmonary functions of asthma patients were determined.Results: In contrast to placebo group, GLC significantly reduced airway hyperreactivity (P< 0.05) and improved clinical symptoms (P<0.05) and pulmonary functions (P<0.05) of the asthmatic patients.Conclusion: GLC is an effective drug of anti-airway inflammation.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    1990; 17(6): 258–262.

  2. 2.

    PAF 1990;13 (4): 197–201.

  3. 3.

    1993;16 5.

  4. 4.

    Barnes PJ. PAF and asthma. J Allergy Clin Immunol 1988; 81: 152–159.

Download references

Author information

Correspondence to Ming-hua Li or Ben-ying Yang or Hong Yu or Hong-liang Zhang.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Li, M., Yang, B., Yu, H. et al. Clinical observation of the therapeutic effect of Ginkgo leaf concentrated oral liquor on bronchial asthma. CJIM 3, 264–267 (1997). https://doi.org/10.1007/BF02934827

Download citation

Key Words

  • Ginkgo leaf concentrated oral liquor
  • asthma
  • airway hyperreactivity
  • pulmonary function